Cholecystokinin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  • Margery Beinfeld Tufts University
  • Quan Chen Mayo Clinic
  • Fan Gao Mayo Clinic
  • Roger A. Liddle Duke University
  • Laurence J. Miller Mayo Clinic
  • Jens Rehfeld University of Copenhagen


Cholecystokinin receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on CCK receptors [89]) are activated by the endogenous peptides cholecystokinin-8 (CCK-8), CCK-33, CCK-58 and gastrin (gastrin-17). There are only two distinct subtypes of CCK receptors, CCK1 and CCK2 receptors [63, 123], with some alternatively spliced forms most often identified in neoplastic cells. The CCK receptor subtypes are distinguished by their peptide selectivity, with the CCK1 receptor requiring the carboxyl-terminal heptapeptide-amide that includes a sulfated tyrosine for high affinity and potency, while the CCK2 receptor requires only the carboxyl-terminal tetrapeptide shared by each CCK and gastrin peptides. These receptors have characteristic and distinct distributions, with both present in both the central nervous system and peripheral tissues.
How to Cite
Beinfeld, M., Chen, Q., Gao, F., Liddle, R. A., Miller, L. J. and Rehfeld, J. (2019) “Cholecystokinin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database”, IUPHAR/BPS Guide to Pharmacology CITE, 2019(4). doi: 10.2218/gtopdb/F15/2019.4.